CLC-7: A potential therapeutic target for the treatment of osteoporosis and neurodegeneration

Biochemical and Biophysical Research Communications

Volumn 384, Issue 3, 2009, Pages 277-279

  Zhao, Qingxiao ^a   Wei, Qun ^a   He, Aimin ^a   Jia, Ruokun ^a   Xiao, Yongtao ^a  

^a NORTHEAST ELECTRIC POWER UNIVERSITY   (China)

Author keywords

CLC 7; Endosomes; Lysosomes; Osteoclasts

Indexed keywords

CHLORIDE CHANNEL; CHLORIDE CHANNEL CLC 7; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; CELL FUNCTION; CELL MEMBRANE; CHANNEL GATING; DISEASE SEVERITY; ENDOSOME; HUMAN; LYSOSOME; NERVE DEGENERATION; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA DEGENERATION; SHORT SURVEY;

ANIMALS; CHLORIDE CHANNELS; HUMANS; MICE; NEURODEGENERATIVE DISEASES; OSTEOPETROSIS; RETINAL DEGENERATION;

MUS;

EID: 65649120105     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.088     Document Type: Short Survey

References (20)

1. + antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453 (2008) 788-792
2. Kornak U., Bosl M.R., and Kubisch C. Complete genomic structure of the CLCN6 and CLCN7 putative chloride channel genes(1). Biochim. Biophys. Acta 1447 (1999) 100-106
3. Kida Y., Uchida S., Miyazaki H., Sasaki S., and Marumo F. Localization of mouse CLC-6 and CLC-7 mRNA and their functional complementation of yeast CLC gene mutant. Histochem. Cell Biol. 115 (2001) 189-194
4. Jentsch T.J., Neagoe I., and Scheel O. CLC chloride channels and transporters. Curr. Opin. Neurobiol. 15 (2005) 319-325
5. Kasper D., Planells-Cases R., Fuhrmann J.C., Scheel O., Zeitz O., Ruether K., Schmitt A., Poet M., Steinfeld R., Schweizer M., Kornak U., and Jentsch T.J. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24 (2005) 1079-1091
6. Eskelinen E.L., Tanaka Y., and Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13 (2003) 137-145
7. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J. Biol. Chem. 266 (1991) 21327-21330
8. Lange P.F., Wartosch L., Jentsch T.J., and Fuhrmann J.C. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440 (2006) 220-223
9. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., Friedrich W., Delling G., and Jentsch T.J. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104 (2001) 205-215
10. Waguespack S.G., Koller D.L., White K.E., Fishburn T., Carn G., Buckwalter K.A., Johnson M., Kocisko M., Evans W.E., Foroud T., and Econs M.J. Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J. Bone Miner. Res. 18 (2003) 1513-1518
11. Frattini A., Pangrazio A., Susani L., Sobacchi C., Mirolo M., Abinun M., Andolina M., Flanagan A., Horwitz E.M., Mihci E., Notarangelo L.D., Ramenghi U., Teti A., Van Hove J., Vujic D., Young T., Albertini A., Orchard P.J., Vezzoni P., and Villa A. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J. Bone Miner. Res. 18 (2003) 1740-1747
12. Cleiren E., Benichou O., Van Hul E., Gram J., Bollerslev J., Singer F.R., Beaverson K., Aledo A., Whyte M.P., Yoneyama T., deVernejoul M.C., and Van Hul W. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum. Mol. Genet. 10 (2001) 2861-2867
13. Chu K., Koller D.L., Snyder R., Fishburn T., Lai D., Waguespack S.G., Foroud T., and Econs M.J. Analysis of variation in expression of autosomal dominant osteopetrosis type 2: searching for modifier genes. Bone 37 (2005) 655-661
14. Campos-Xavier A.B., Casanova J.L., Doumaz Y., Feingold J., Munnich A., and Cormier-Daire V. Intrafamilial phenotypic variability of osteopetrosis due to chloride channel 7 (CLCN7) mutations. Am. J. Med. Genet. A 133A (2005) 216-218
15. Kornak U., Ostertag A., Branger S., Benichou O., and de Vernejoul M.C. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II. J. Clin. Endocrinol. Metab. 91 (2006) 995-1000
16. Steward C.G. Neurological aspects of osteopetrosis. Neuropathol. Appl. Neurobiol. 29 (2003) 87-97
17. Henriksen K., Sorensen M.G., Jensen V.K., Dziegiel M.H., Nosjean O., and Karsdal M.A. Ion transporters involved in acidification of the resorption lacuna in osteoclasts. Calcif. Tissue Int. 83 (2008) 230-242
18. Schaller S., Henriksen K., Sorensen M.G., and Karsdal M.A. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment. Drug News Perspect. 18 (2005) 489-495
19. Schaller S., Henriksen K., Sveigaard C., Heegaard A.M., Helix N., Stahlhut M., Ovejero M.C., Johansen J.V., Solberg H., Andersen T.L., Hougaard D., Berryman M., Shiodt C.B., Sorensen B.H., Lichtenberg J., Christophersen P., Foged N.T., Delaisse J.M., Engsig M.T., and Karsdal M.A. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation. J. Bone Miner. Res. 19 (2004) 1144-1153
20. Gerritsen E.J., Vossen J.M., Fasth A., Friedrich W., Morgan G., Padmos A., Vellodi A., Porras O., O'Meara A., Porta F., et al. Bone marrow transplantation for autosomal recessive osteopetrosis. J. Pediatr. 125 (1994) 896-902